New Antithrombotic Agents

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 715S-727S

  Weitz, Jeffrey I ^a   Hirsh, Jack ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; BARBOURIN; CLOPIDOGREL; DISINTEGRIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IB; HIRUDIN; HIRUGEN; HIRULOG; INOGATRAN; LAMIFIBAN; MELAGATRAN; MONOCLONAL ANTIBODY; NAPSAGATRAN; OROFIBAN; PEPTIDE DERIVATIVE; SIBRAFIBAN; THROMBOXANE RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR; TICLOPIDINE; TIROFIBAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XEMILOFIBAN;

CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY THROMBOSIS; DRUG MECHANISM; FIBRINOLYSIS; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOGENESIS;

EID: 0031729333     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5_Supplement.715S     Document Type: Conference Paper

References (8)

1. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326:242-250
2. Hanson SR, Harker LA. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci (USA) 1988; 85:3184-3188
3. Krupski WC, Bass A, Kelly AB, et al. Heparin resistant thrombus formation by endovascular stents in baboons: interruption by a synthetic antithrombin. Circulation 1990; 82:570-572
4. Hogg PJ, Jackson CM. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy. Proc Natl Acad Sci (USA) 1989; 86:3619-3623
5. Weitz JI, Hudoba M, Massel D, et al. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990; 86:385-391
6. Eisenberg PR, Siegel JE, Abendschein DR, et al. Importance of factor Xa in determining the procoagulant activity of whole-blood clots. J Clin Invest 1993; 91:1877-1883
7. Kumar R, Beguin S, Hemker C. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity. Thromb Haemost 1995; 74:962-968
8. Kumar R, Beguin S, Hemker C. The influence of fibrinogen and fibrin on thrombin generation - evidence for feedback activation of the clotting system by clot bound thrombin. Thromb Haemost 1994; 72:713-721